These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 24392129)
1. Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. Terzuoli E; Meini S; Cucchi P; Catalani C; Cialdai C; Maggi CA; Giachetti A; Ziche M; Donnini S PLoS One; 2014; 9(1):e84358. PubMed ID: 24392129 [TBL] [Abstract][Full Text] [Related]
2. Bradykinin B2 Receptor Contributes to Inflammatory Responses in Human Endothelial Cells by the Transactivation of the Fibroblast Growth Factor Receptor FGFR-1. Terzuoli E; Corti F; Nannelli G; Giachetti A; Donnini S; Ziche M Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200598 [TBL] [Abstract][Full Text] [Related]
3. Involvement of Bradykinin B2 Receptor in Pathological Vascularization in Oxygen-Induced Retinopathy in Mice and Rabbit Cornea. Terzuoli E; Morbidelli L; Nannelli G; Giachetti A; Donnini S; Ziche M Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360776 [TBL] [Abstract][Full Text] [Related]
4. Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E₂ release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes. Meini S; Cucchi P; Tinti L; Niccolini S; Bellucci F; Catalani C; Valenti C; Galeazzi M; Fioravanti A; Maggi CA Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):777-86. PubMed ID: 22638761 [TBL] [Abstract][Full Text] [Related]
5. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis. Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080 [TBL] [Abstract][Full Text] [Related]
6. Bradykinin and B₂ receptor antagonism in rat and human articular chondrocytes. Meini S; Cucchi P; Catalani C; Bellucci F; Giuliani S; Maggi CA Br J Pharmacol; 2011 Feb; 162(3):611-22. PubMed ID: 20946124 [TBL] [Abstract][Full Text] [Related]
7. Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts. Bellucci F; Cucchi P; Catalani C; Giuliani S; Meini S; Maggi CA Br J Pharmacol; 2009 Dec; 158(8):1996-2004. PubMed ID: 20050188 [TBL] [Abstract][Full Text] [Related]
8. Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant. Gomis A; Meini S; Miralles A; Valenti C; Giuliani S; Belmonte C; Maggi CA Osteoarthritis Cartilage; 2013 Sep; 21(9):1346-54. PubMed ID: 23973149 [TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis. Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945 [TBL] [Abstract][Full Text] [Related]
10. Bradykinin B2 receptor mediates NF-kappaB activation and cyclooxygenase-2 expression via the Ras/Raf-1/ERK pathway in human airway epithelial cells. Chen BC; Yu CC; Lei HC; Chang MS; Hsu MJ; Huang CL; Chen MC; Sheu JR; Chen TF; Chen TL; Inoue H; Lin CH J Immunol; 2004 Oct; 173(8):5219-28. PubMed ID: 15470067 [TBL] [Abstract][Full Text] [Related]
11. Bradykinin receptor in immune-mediated renal tubular injury in trichloroethylene-sensitized mice: Impact on NF-κB signaling pathway. Yang L; Zhang J; Li N; Xie H; Chen S; Wang H; Shen T; Zhu QX J Immunotoxicol; 2018 Dec; 15(1):126-136. PubMed ID: 30409067 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of angiogenic cellular processes and claudin-5 by histamine and VEGF via PI3K-signaling, transcription factor SNAI2 and interleukin-8. Laakkonen JP; Lappalainen JP; Theelen TL; Toivanen PI; Nieminen T; Jauhiainen S; Kaikkonen MU; Sluimer JC; Ylä-Herttuala S Angiogenesis; 2017 Feb; 20(1):109-124. PubMed ID: 27873103 [TBL] [Abstract][Full Text] [Related]
13. Bradykinin alleviates DR retinal endothelial injury by regulating HMGB-1/NF-κB pathway. Zhu Y; Li XY; Wang J; Zhu YG Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5535-5541. PubMed ID: 31298304 [TBL] [Abstract][Full Text] [Related]
14. Liver kinase B1 is required for thromboxane receptor-dependent nuclear factor-κB activation and inflammatory responses. He J; Zhou Y; Xing J; Wang Q; Zhu H; Zhu Y; Zou MH Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1297-305. PubMed ID: 23539217 [TBL] [Abstract][Full Text] [Related]
15. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts. Lee CH; Shieh DC; Tzeng CY; Chen CP; Wang SP; Chiu YC; Huang CY; Hsu CJ; Fong YC; Tang CH Mol Immunol; 2008 Aug; 45(14):3693-702. PubMed ID: 18621420 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits BK-induced COX-2 transcription by suppressing acetylation of AP-1 and NF-κB in human rheumatoid arthritis synovial fibroblasts. Yang CM; Chen YW; Chi PL; Lin CC; Hsiao LD Biochem Pharmacol; 2017 May; 132():77-91. PubMed ID: 28288820 [TBL] [Abstract][Full Text] [Related]
17. Didymin by suppressing NF-κB activation prevents VEGF-induced angiogenesis in vitro and in vivo. Shukla K; Sonowal H; Saxena A; Ramana KV Vascul Pharmacol; 2019 Apr; 115():18-25. PubMed ID: 30634049 [TBL] [Abstract][Full Text] [Related]
18. Decrease of intracellular chloride concentration promotes endothelial cell inflammation by activating nuclear factor-κB pathway. Yang H; Huang LY; Zeng DY; Huang EW; Liang SJ; Tang YB; Su YX; Tao J; Shang F; Wu QQ; Xiong LX; Lv XF; Liu J; Guan YY; Zhou JG Hypertension; 2012 Nov; 60(5):1287-93. PubMed ID: 23006728 [TBL] [Abstract][Full Text] [Related]
19. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Miura S; Matsuo Y; Saku K Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712 [TBL] [Abstract][Full Text] [Related]
20. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists. Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]